Meta-Analysis
Answers are grounded in this paper and cite their sources.
Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832–9. [OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q In patients with heart failure, vascular disease, hypertension, or electrical cardioversion for atrial fibrillation (AF), do angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) prevent the development or recurrence of AF? Clinical impact ratings Internal medicine ★★★★★★☆ Cardiology ★★★★★★☆ ### ![Graphic][5] Data sources: Medline and EMBASE/Excerpta Medica (from 1980), abstracts of scientific meetings (past 4 y), reference lists of relevant articles, and contact with authors of appropriate trials that did not publish AF outcomes. ### ![Graphic][6] Study selection and assessment: randomised controlled trials (RCTs) with a parallel design, published in English, that compared an ACE inhibitor or ARB with placebo, no treatment, or an alternate … [1]: {openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BAmerican%2BCollege%2Bof%2BCardiology%26rft.stitle%253DJ%2BAm%2BColl%2BCardiol%26rft.issn%253D0735-1097%26rft.aulast%253DHealey%26rft.auinit1%253DJ.%2BS.%26rft.volume%253D45%26rft.issue%253D11%26rft.spage%253D1832%26rft.epage%253D1839%26rft.atitle%253DPrevention%2Bof%2BAtrial%2BFibrillation%2BWith%2BAngiotensin-Converting%2BEnzyme%2BInhibitors%2Band%2BAngiotensin%2BReceptor%2BBlockers%253A%2BA%2BMeta-Analysis%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jacc.2004.11.070%26rft_id%253Dinfo%253Apmid%252F15936615%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1016/j.jacc.2004.11.070&link_type=DOI [3]: /lookup/external-ref?access_num=15936615&link_type=MED&atom=%2Febmed%2F11%2F1%2F15.atom [4]: /lookup/external-ref?access_num=000229593000018&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif
No takes yet. Share an insight, caveat, or question.
V. Karthikeyan (2006) conducted a meta-analysis in Heart failure, vascular disease, hypertension, or electrical cardioversion for atrial fibrillation (AF). Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) vs. Placebo, no treatment, or an alternate therapy was evaluated on Development or recurrence of atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: